Healthcare provider profile · identity verified

David R. Craney, MD

Internal Medicine · ALAMEDA, CA · NPI 1144308941

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	637	214
Losartan Potassium	Losartan Potassium	414	131
Amlodipine Besylate	Amlodipine Besylate	349	124
Lisinopril	Lisinopril	199	69
Tamsulosin Hcl	Tamsulosin Hcl	199	64
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	174	54
Levothyroxine Sodium	Levothyroxine Sodium	157	49
Albuterol Sulfate Hfa	Albuterol Sulfate	149	81
Metoprolol Tartrate	Metoprolol Tartrate	144	49
Metformin Hcl Er	Metformin Hcl	132	56
Pantoprazole Sodium	Pantoprazole Sodium	116	44
Fluticasone Propionate	Fluticasone Propionate	115	41
Trazodone Hcl	Trazodone Hcl	104	38
Gabapentin	Gabapentin	91	33
Triamcinolone Acetonide	Triamcinolone Acetonide	86	40
Metoprolol Succinate	Metoprolol Succinate	83	32
Tizanidine Hcl	Tizanidine Hcl	78	35
Hydrochlorothiazide	Hydrochlorothiazide	77	27
Famotidine	Famotidine	74	42
Terazosin Hcl	Terazosin Hcl	72	23
Allopurinol	Allopurinol	70	28
Lorazepam	Lorazepam	70	21
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	65	65
Meloxicam	Meloxicam	60	31
Tadalafil	Tadalafil	59	16
Furosemide	Furosemide	58	22
Wixela Inhub	Fluticasone Propion/Salmeterol	55	13
Cephalexin	Cephalexin	54	44
Jardiance	Empagliflozin	51	24
Atenolol	Atenolol	50	16
Escitalopram Oxalate	Escitalopram Oxalate	49	23
Metformin Hcl	Metformin Hcl	48	19
Hydrocortisone	Hydrocortisone	47	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	18
Rosuvastatin Calcium	Rosuvastatin Calcium	46	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	15
Omeprazole	Omeprazole	44	23
Simvastatin	Simvastatin	43	20
Acyclovir	Acyclovir	42	16
Colchicine	Colchicine	42	20
Acetaminophen-Codeine	Acetaminophen With Codeine	41	suppressed
Fluocinonide	Fluocinonide	41	23
Ibuprofen	Ibuprofen	40	21
Bupropion Xl	Bupropion Hcl	37	suppressed
Azithromycin	Azithromycin	34	34
Pravastatin Sodium	Pravastatin Sodium	32	13
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Alvesco	Ciclesonide	29	14
Spironolactone	Spironolactone	29	suppressed
Glipizide	Glipizide	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	12
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Prednisone	Prednisone	26	17
Finasteride	Finasteride	25	suppressed
Topiramate	Topiramate	25	suppressed
Carvedilol	Carvedilol	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Sertraline Hcl	Sertraline Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	21	13
Memantine Hcl	Memantine Hcl	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Mupirocin	Mupirocin	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Cefuroxime	Cefuroxime Axetil	12	11
Potassium Chloride	Potassium Chloride	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Lactulose	Lactulose	11	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error